All PTX-3 articles
-
NewsPotential biomarker for the development of long COVID identified
A research team has demonstrated that a specific component of the immune system (PTX-3) remains at significantly higher levels in the blood of patients who have suffered from severe COVID-19, even months after the acute infection has subsided.